Subsequent infections in survivors of sepsis: Epidemiology and outcomes

Journal of Intensive Care Medicine

Volumn 29, Issue 2, 2014, Pages 87-95

  Wang, Tisha ^a   Derhovanessian, Ariss ^a   De Cruz, Sharon ^a   Belperio, John A ^a   Deng, Jane C ^a   Hoo, Guy Soo ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

immunosuppression; outcomes; sepsis

Indexed keywords

AGED; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DISEASE SEVERITY; FEMALE; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITAL READMISSION; HUMAN; INCIDENCE; INFECTION RISK; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RECURRENT INFECTION; REVIEW; SEPSIS; SURVIVOR;

IMMUNOSUPPRESSION; OUTCOMES; SEPSIS;

AGED; APACHE; CASE-CONTROL STUDIES; CHRONIC DISEASE; COMORBIDITY; ENDPOINT DETERMINATION; FEMALE; HUMANS; INTENSIVE CARE UNITS; LOS ANGELES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT ADMISSION; PATIENT READMISSION; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; SEPSIS; SEVERITY OF ILLNESS INDEX; SURVIVORS; TERTIARY CARE CENTERS; TREATMENT OUTCOME; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 84896131878     PISSN: 08850666     EISSN: 15251489     Source Type: Journal    
DOI: 10.1177/0885066612467162     Document Type: Review

References (24)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001 ; 29 (7). 1303-1310
2. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003 ; 348 (16). 1546-1554
3. Winters BD, Eberlein M, Leung J, Needham DM, Pronovost PJ, Sevransky JE. Long-term mortality and quality of life in sepsis: a systematic review. Crit Care Med. 2010 ; 38 (5). 1276-1283
4. Quartin AA, Schein RM, Kett DH, Peduzzi PN. Magnitude and duration of the effect of sepsis on survival. Department of Veterans Affairs Systemic Sepsis Cooperative Studies Group. JAMA. 1997 ; 277 (13). 1058-1063
5. Wang TS, Deng JC. Molecular and cellular aspects of sepsis-induced immunosuppression. J Mol Med (Berl). 2008 ; 86 (5). 495-506
6. Boomer JS, To K, Chang KC, et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA. 2011 ; 306 (23). 2594-2605
7. Fink MP, Heard SO. Laboratory models of sepsis and septic shock. J Surg Res. 1990 ; 49 (2). 186-196
8. Volk HD, Reinke P, Krausch D, et al. Monocyte deactivation - rationale for a new therapeutic strategy in sepsis. Intensive Care Med. 1996 ; 22 (suppl 4). S474 - S481
9. Bone RC. Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann Intern Med. 1996 ; 125 (8). 680-687
10. Calandra T, Cohen J. The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med. 2005 ; 33 (7). 1538-1548
11. Nelson WB. Confidence limits for recurrence data - applied to cost or number of repairs. Technometrics. 1995 ; 37: 147-157
12. Lawless JF, Nadeau C.. Some simple robust methods for the analysis of recurrent events. Technometrics. 1995 ; 37: 158-168
13. Lin DY, Wei LJ, Yang I, Ying Z. Semiparametric regression for the mean and rate functions of recurrent events. J R Statis Soc B. 2000 ; 62: 711-730
14. Pepe MS, Cai J. Some graphical displays and marginal regression analyses for recurrent failure times and time dependent covariates. J Am Statist Ass. 1993 ; 88: 811-820
15. Karlsson S, Ruokonen E, Varpula T, Ala-Kokko TI, Pettila V. Long-term outcome and quality-adjusted life years after severe sepsis. Crit Care Med. 2009 ; 37 (4). 1268-1274
16. Laupland KB, Zygun DA, Doig CJ, Bagshaw SM, Svenson LW, Fick GH. One-year mortality of bloodstream infection-associated sepsis and septic shock among patients presenting to a regional critical care system. Intensive Care Med. 2005 ; 31 (2). 213-219
17. Weycker D, Akhras KS, Edelsberg J, Angus DC, Oster G. Long-term mortality and medical care charges in patients with severe sepsis. Crit Care Med. 2003 ; 31 (9). 2316-2323
18. Deng JC, Cheng G, Newstead MW, et al. Sepsis-induced suppression of lung innate immunity is mediated by IRAK-M. J Clin Invest. 2006 ; 116 (9). 2532-2542
19. Chen GH, Reddy RC, Newstead MW, Tateda K, Kyasapura BL, Standiford TJ. Intrapulmonary TNF gene therapy reverses sepsis-induced suppression of lung antibacterial host defense. J Immunol. 2000 ; 165 (11). 6496-6503
20. Blajchman MA, Bordin JO. Mechanisms of transfusion-associated immunosuppression. Curr Opin Hematol. 1994 ; 1 (6). 457-461
21. Blajchman MA. Transfusion immunomodulation or TRIM: what does it mean clinically?. Hematology. 2005 ; 10 (suppl 1). 208-214
22. Keegan MT, Gajic O, Afessa B. Severity of illness scoring systems in the intensive care unit. Crit Care Med. 2011 ; 39 (1). 163-169
23. Laupland KB, Gregson DB, Zygun DA, Doig CJ, Mortis G, Church DL. Severe bloodstream infections: a population-based assessment. Crit Care Med. 2004 ; 32 (4). 992-997
24. Hoste EA, Clermont G, Kersten A, et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care. 2006 ; 10 (3). R73